Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

809129

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	What recent assessment he has made of trends in the level of fines in relation to dental and prescription charges.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	903036
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The NHS Business Services Authority (NHS BSA) issues penalty charge notices (PCNs) for incorrect claims for exemption from National Health Service dental and prescription charges.</p><p>To ensure the integrity of the exemption system the NHS BSA has recently increased the number of checks. In 2016/17, 365,181 PCNs for dental charges and 975,065 for prescription charges were issued. This represents an increase of 90.11% and 90.23%, respectively, on 2015/16. There is a clear process for patients to appeal a PCN if they believe it is unjustified.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:09:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4471 label Biography information for Rachael Maskell

837681

	registered interest
	date	06/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Labour Turnover
	house id	1
	legislature	25259 pref label House of Commons
	question text	What estimate his Department has made of the number of GPs who plan to leave general practice in the next five years; and if he will make a statement.
	tabling member constituency	Rochdale
	tabling member printed	Tony Lloyd
	uin	903795
	answer	answer is ministerial correction date of answer 06/02/2018 answer text <p>We know that one of the main reasons GPs leave general practice is retirement. That is why we have put in place comprehensive measures to ensure we meet our commitment of an extra 5,000 GPs in the NHS by 2020. GP Career Plus, the GP Retention Scheme and the National GP Induction and Refresher Scheme will all help get valuable experienced GPs back into our NHS. 3,157 GP training places were also filled in 2017 – the highest number ever.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 06/02/2018 15:44:28 answering member 4067 label Biography information for Steve Brine
	tabling member	450 label Biography information for Tony Lloyd

809126

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Skin Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	What estimate he has made of the number of patients with Erythropoietic Protoporphyria.
	tabling member constituency	Newport East
	tabling member printed	Jessica Morden
	uin	903031
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>In 2016/17 there were 54 National Health Service admissions in England with a primary diagnosis of Erythropoietic Protoporphyria.</p><p> </p><p>Whilst the numbers of people with a particular rare disease can be very small, 3.5 million people in the United Kingdom have a rare disease. We know, as with the hon. Member’s constituent, that these diseases can have a heart-breaking impact on a person’s health.</p><p> </p><p>That‘s why the UK is committed to building on our position as a world-leader in the diagnosis and treatment of rare diseases.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:07:30 answering member 4067 label Biography information for Steve Brine
	tabling member	1548 label Biography information for Jessica Morden

828794

	registered interest
	date	23/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Kidney Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State, if he will take steps to ensure that people with diabetes are offered urine and blood tests to check for chronic kidney disease.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	124426
	answer	answer is ministerial correction date of answer 31/01/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) has published guidance on ‘Chronic kidney disease in adults’ which sets out best practice for clinicians on the diagnosis, treatment, care, and support of patients with chronic kidney disease (CKD). The guidance also includes recommendations for those at risk of developing CKD, including people with diabetes. NHS England expects commissioners to take account of NICE guidelines when delivering services.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 31/01/2018 12:34:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4127 label Biography information for Julie Elliott

807191

	registered interest
	date	15/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the commercial agreement announced by NHS England on 9 November 2017, what the timetable is for NICE to issue final guidance on Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel for HER2 positive metastatic or locally recurrent unresectable breast cancer.
	tabling member constituency	North Warwickshire
	tabling member printed	Craig Tracey
	uin	119837
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>The timetable for the National Institute for Health and Care Excellence’s (NICE) guidance on Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and docetaxel for HER2 positive metastatic or locally recurrent unresectable breast cancer is still to be confirmed. Perjeta remains available to new and existing National Health Service patients through the Cancer Drugs Fund pending NICE’s final guidance.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 11:38:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4509 label Biography information for Craig Tracey

804559

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the NHS England document, Next Steps on the Five Year Forward View published in March 2017, what recent progress the NHS has made on meeting the objective for an extra 5,000 people to survive cancer over the next two years.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118761
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>Earlier and faster diagnosis is key to improving survival rates and NHS England is investing over £200 million over the next two years in cancer services to encourage local areas to find new and innovative ways to diagnose cancer earlier, improve the care for those living with cancer and ensure each cancer patient gets the right care for them. The Government has also committed £130 million for new technology and equipment to ensure patients have access to the best and latest radiotherapy treatment.</p><p> </p><p>Survival rates from cancer in England are at a record high, and since 2010 rates of survival from cancer have increased year-on-year. The decrease in cancer deaths means that around 7,000 people are alive today who would not have been had things stayed the same. One year survival rates for the period 2017-19 will be available in 2021.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:30:05 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

818651

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Innovative Medicines and Medical Technology Review
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Government response to the Accelerated Access Review published in November 2017, what plans his Department has to streamline existing routes to market for medical technologies, devices and diagnostics.
	tabling member constituency	East Kilbride, Strathaven and Lesmahagow
	tabling member printed	Dr Lisa Cameron
	uin	121415
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>We are introducing a new Accelerated Access Pathway, to streamline regulatory and market access decisions, getting breakthrough products that we believe will be truly transformative to patients more quickly. A new Accelerated Access Collaborative (AAC) chaired by Sir Andrew Witty, will develop and own the Accelerated Access Pathway which will be operational from April 2018. All products including medical technologies, devices and diagnostics will be eligible for selection. In addition to the new Pathway, the AAC will also make recommendations to the Government and its partners about opportunities to further streamline existing routes to market.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/01/2018 12:04:46 answering member 4067 label Biography information for Steve Brine
	tabling member	4412 label Biography information for Dr Lisa Cameron

818756

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	High Weald Lewes Havens Clinical Commissioning Group
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Answer of 8 November 2016 to Question 51429, if he will publish a copy of the validated analysis of costs provided by Coperforma Ltd to the High Weald Havens Clinical Commissioning Group referred to in that Answer; what the value is of invoices the High Weald Havens Clinical Commissioning Group received directly from each trust which incurred private ambulance costs arising from performance problems with Patient Transport Services provided by Coperforma and arms length driver operatives; and if he will make a statement.
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	uin	121520
	answer	answer is ministerial correction date of answer 16/01/2018 answer text <p>The information requested is not collected centrally.</p><p>The provision of patient transport services is a matter for local National Health Service commissioners. NHS England has advised that High Weald Havens Clinical Commissioning Group commissioned an independent investigation into these events, which reported in March 2017. Accordingly, there are no plans to undertake a further independent investigation.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121516 121517 question first answered 16/01/2018 16:19:44 answering member 4067 label Biography information for Steve Brine
	tabling member	3930 label Biography information for Caroline Lucas

805229

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to NHS England's press release of 28 July 2016 entitled World Hepatitis Day: a chance to reflect on achievements to date and redouble efforts, what discussions his Department has had with NHS England on developing more innovative, longer-term proposals for the treatment of hepatitis C.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118901
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>Following a procurement process that concluded in September 2017, NHS England has secured further improvements in pricing of hepatitis C treatments, including through an innovative ‘pay per cure’ approach. NHS England’s detailed work to design an innovative, longer-term approach to hepatitis C treatment procurement has continued and it is anticipated that this will be shared with suppliers early in 2018.</p><p> </p><p>NHS England spent in excess of £200 million on direct acting antivirals for hepatitis C in 2016-17 and is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence, apportioned to local Operational Delivery Networks based on estimated local health needs.</p><p> </p><p>NHS England is planning a sustainable roll out of treatment which will complete the treatment of 71,000 individuals between 2015/16 and 2020/21.</p><p> </p><p>Commercial and contractual activity undertaken by NHS England is already securing reduced prices to allow expanded treatment rates within available resources.</p><p> </p><p>Various initiatives are underway in England to improve awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres recognising the challenges inherent in a pathway where there are multiple commissioners and providers and budgetary constraints.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:27:51 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

809659

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to Age UK’s Painful Journeys campaign, what steps his Department is taking to make travelling to and from hospital easier for older people.
	tabling member constituency	Sheffield Central
	tabling member printed	Paul Blomfield
	uin	120279
	answer	answer is ministerial correction date of answer 27/12/2017 answer text <p>The provision of appropriate patient transport services (PTS) in line with national guidance is a matter for local National Health Service commissioners.</p><p> </p><p>The Department is clear that medically eligible patients must have appropriate access to quality PTS to outpatient appointments. The document ‘Eligibility Criteria for Patient Transport Services’ sets out criteria for establishing which patients are eligible for non-emergency PTS. The guidance states that eligible patients should reach appointments in reasonable time and in reasonable comfort, without detriment to their medical condition.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/12/2017 11:03:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4058 label Biography information for Paul Blomfield

810724

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accountable Care Organisations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, who is responsible for determining the membership of an Accountable Care Organisation.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	121069
	answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>In the very small number of places where local commissioners are running procurements for the award of such contracts, local National Health Service foundation trusts, NHS trusts and general practitioners have been selected as partners for delivery of those contracts.</p><p> </p><p>The selection of an appropriate provider to hold such a contract will continue to be a matter for local NHS commissioners, and those commissioners must make that selection by way of a process which is compliant with the requirements of the Public Contract Regulations 2015. These involve openness, transparency and equal treatment of potential providers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120591 question first answered 11/01/2018 16:52:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

806468

	registered interest
	date	14/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which prescription drugs increased proportionately the most in cost to the public purse in each of the last 10 years for which data is available.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	119544
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The information requested is presented in the table below.</p><p> </p><p>Prescription medicines have only been included where there was prescribing in both 2006 and 2016. The medicines have been ranked on the highest average annual increase from 2006 to 2016 and the top five drugs are shown at presentation level.</p><p> </p><p>Where the Net Ingredient Cost (NIC) is shown to be £0.00, this is in fact rounded and the true figure is between £0.00 and £0.01 which is calculated by dividing the NIC by quantity.</p><p> </p><p>Top five medicines with the largest average annual percentage increase, 2006-16, for NIC per quantity</p><table><tbody><tr><td><p>Drug name</p></td><td><p>NIC 2006</p></td><td><p>NIC 2016</p></td><td><p>Average annual percentage change, 2006 - 16</p></td></tr><tr><td><p>Hydrogen Peroxide Ear Drops 1.5%</p></td><td><p>£0.02</p></td><td><p>£33.28</p></td><td><p>111.1</p></td></tr><tr><td><p>Potassium Permanganate Solution 0.1%</p></td><td><p>£0.00</p></td><td><p>£1.11</p></td><td><p>102.5</p></td></tr><tr><td><p>Proflavine Solution 0.1%</p></td><td><p>£0.00</p></td><td><p>£0.42</p></td><td><p>80.1</p></td></tr><tr><td><p>Sodium Chloride Solution 0.9%</p></td><td><p>£0.00</p></td><td><p>£0.36</p></td><td><p>73.6</p></td></tr><tr><td><p>Bismuth Subgallate Suppository 300mg</p></td><td><p>£0.14</p></td><td><p>£32.97</p></td><td><p>72.9</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:25:29 answering member 4067 label Biography information for Steve Brine
	tabling member	534 label Biography information for Chris Ruane

816943

	registered interest
	date	05/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups: Sponsorship
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which Clinical Commissioning Groups have a policy of not accepting sponsorship from drug companies and similar organisations; and whether his Department plans to regulate or stop such sponsorship arrangements.
	tabling member constituency	Preston
	tabling member printed	Sir Mark Hendrick
	uin	121370
	answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>NHS England does not collect data centrally on which clinical commissioning groups (CCGs) have a policy of not accepting sponsorship from drug companies and similar organisations. NHS England published statutory guidance on managing conflicts of interest for CCGs in June 2017 which aims to support CCGs to identify and manage a range of conflicts of interests, which is available at the following link:</p><p> </p><p>https://www.england.nhs.uk/wp-content/uploads/2017/06/revised-ccg-coi-guidance-jul-17.pdf</p><p> </p><p>This guidance addresses the issue of sponsorship. In addition, NHS England published system-wide guidance in February 2017 on managing conflicts of interest in the NHS which is available at the following link:</p><p> </p><p>https://www.england.nhs.uk/wp-content/uploads/2017/02/guidance-managing-conflicts-of-interest-nhs.pdf</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 17:39:53 answering member 4067 label Biography information for Steve Brine
	tabling member	473 label Biography information for Sir Mark Hendrick

810702

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	EU Rapid Alert Systems for Food and Feed
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the UK will continue to participate in the EU Rapid Alert Systems for Food and Feed after the UK leaves the EU.
	tabling member constituency	Plymouth, Sutton and Devonport
	tabling member printed	Luke Pollard
	uin	121047
	answer	answer is ministerial correction date of answer 08/01/2018 answer text <p>The Rapid Alert System for Food and Feed is important in enabling the management of food and feed safety risks by providing early alerts of health or food contamination issues across the European Union. At present, this enables the United Kingdom to respond quickly to serious risks to public health relating to food and animal feed. The Government is considering the best approach for the management of notification of food and feed safety risks once we have left the EU. It will be our priority to maintain the UK’s high standards of food and feed safety, and continue to be able to provide a timely response to food safety incidents. This is essential for the protection of public health, and for maintaining consumer confidence in food.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/01/2018 16:36:22 answering member 4067 label Biography information for Steve Brine
	tabling member	4682 label Biography information for Luke Pollard

804397

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Education: Vegetables
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether the Department for Health has issued guidance to people about increasing their vegetable intake.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	118532
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The Government recommends eating at least five portions of a variety of fruit and vegetables a day as part of a healthy balanced diet.</p><p> </p><p>This is reflected through a variety of communications including the Eatwell Guide - Public Health England’s catering guidance, available at:</p><p> </p><p><a href="https://www.gov.uk/government/publications/healthier-and-more-sustainable-catering-a-toolkit-for-serving-food-to-adults" target="_blank">https://www.gov.uk/government/publications/healthier-and-more-sustainable-catering-a-toolkit-for-serving-food-to-adults</a></p><p> </p><p>The Government’s 5 A Day campaign through the Change4Life campaign and the NHS Choices website.</p><p> </p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:39:38 answering member 4067 label Biography information for Steve Brine
	tabling member	338 label Biography information for Keith Vaz

816845

	registered interest
	date	05/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Gluten-free Foods: Prescriptions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether staple gluten-free foods will continue to be available on prescription for people with coeliac disease.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	121272
	answer	answer is ministerial correction date of answer 15/01/2018 answer text <p>A report has been prepared on the responses to the consultation on the availability of gluten free foods on prescription, which will be published alongside the Government’s decision in due course. Meanwhile, a range of staple gluten free foods continue to be available on prescription for patients with established gluten sensitivity enteropathies, including coeliac disease.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/01/2018 11:25:09 answering member 4067 label Biography information for Steve Brine
	tabling member	4658 label Biography information for Alex Sobel

805292

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners: Advertising
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether it is his policy to allow GP practices to undertake advertising campaigns.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	118964
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>Providing information to patients is an important part of general practice as this enables patients to understand the services available.</p><p> </p><p>Currently, there is no national guidance around the advertising of general practitioner (GP) services. However, the joint Royal College of General Practitioners and General Practitioners Committee guidance states that information about GP medical services must be factual and verifiable. The guidance also states GP practices must not make unjustifiable claims about the quality or outcomes of their services in any information they provide to patients. They must not put pressure on people to use a service, for instance, by arousing ill-founded fears for their future health. The guidance further states that the information provided by a practice should avoid making comparisons with others.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:23:13 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

805283

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether it is his policy to allow GP practices to exclude patients from their register on the basis of pregnancy, age, substance dependence or complexity?
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	118955
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>Under the terms of their contracts, general practitioner (GP) practices must have reasonable grounds to remove a patient from their practice list which do not relate to the patient’s race, gender, social class, age, religion, sexual orientation, appearance, disability or medical condition.</p><p> </p><p>If a patient feels that the decision to remove them from their list relates to any of these conditions, they may raise a complaint with NHS England. It is the role of NHS England to ensure GP practices meet the terms of their contract.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:05:32 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

810125

	registered interest
	date	20/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accountable Care Organisations: Private Sector
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether it is his Department's policy that contracts associated with the formation of Accountable Care Organisations will not be outsourced to the private sector.
	tabling member constituency	Glasgow East
	tabling member printed	David Linden
	uin	120591
	answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>In the very small number of places where local commissioners are running procurements for the award of such contracts, local National Health Service foundation trusts, NHS trusts and general practitioners have been selected as partners for delivery of those contracts.</p><p> </p><p>The selection of an appropriate provider to hold such a contract will continue to be a matter for local NHS commissioners, and those commissioners must make that selection by way of a process which is compliant with the requirements of the Public Contract Regulations 2015. These involve openness, transparency and equal treatment of potential providers.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121069 question first answered 11/01/2018 16:52:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4640 label Biography information for David Linden

806455

	registered interest
	date	14/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	GP at Hand: Homelessness
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether homeless people are able to register with the GP at hand service.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	119531
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>Homeless patients are entitled to register with GP at Hand, in the same way as with any other general practitioner (GP) practice, using a temporary address, which may be a friend’s address or a day centre. The practice may also use the practice address to register homeless patients if they wish.</p><p> </p><p>GP at Hand offer traditional general medical services to patients registered with them. The enhanced model they are implementing now focuses on a digital first service through the use of a mobile app which is provided by Babylon Health. Due to the digital element of the service, GP at Hand may not be suitable for all patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:28:20 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

805228

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hepatitis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department plans to publish a strategy to eliminate hepatitis C.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118900
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>The Government is committed to meeting the World Health Organization target of eliminating hepatitis C by 2030 but there are no plans at this time to publish a strategy to eliminate hepatitis C. A variety of initiatives are underway in England to improve awareness and case finding, re-engagement and linkage to care, especially in drug services, primary care, prisons and accident and emergency centres. In addition, NHS England is funding access to new hepatitis C treatments in accordance with guidance from the National Institute for Health and Care Excellence.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:24:50 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

810654

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department plans to introduce automatic insulin delivery devices for people who live with diabetes; and if he will make a statement.
	tabling member constituency	South Antrim
	tabling member printed	Paul Girvan
	uin	120999
	answer	answer is ministerial correction date of answer 09/01/2018 answer text <p>Clinical commissioning groups (CCGs) are primarily responsible for commissioning diabetes services. In doing so, CCGs need to ensure that the services they provide are fit for purpose, reflect the needs of the local population, are based on the available evidence, and take into account national guidelines. This would apply to automatic insulin delivery devices, which would need to be both licensed and assessed for clinical and cost-effectiveness.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 09/01/2018 16:11:10 answering member 4067 label Biography information for Steve Brine
	tabling member	4633 label Biography information for Paul Girvan

804444

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ophthalmic Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department plans to implement a national strategy for ocular health.
	tabling member constituency	Battersea
	tabling member printed	Marsha De Cordova
	uin	118643
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>There are no plans to develop a national strategy for eye health. Given the size of England, and the diversity of the health needs of different communities, we believe commissioning needs to be owned and managed locally. However, the Department supports Vision UK, an umbrella organisation for the eye health and sight loss sector, which aims to improve eye health and end sight loss, improve support across eye health and social care services and improve awareness of sight loss.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:34:49 answering member 4067 label Biography information for Steve Brine
	tabling member	4676 label Biography information for Marsha De Cordova

806664

	registered interest
	date	14/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Contraceptives: Pregnancy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department plans to conduct controlled studies into the effects of ellaOne in pregnant women; and if he will make a statement.
	tabling member constituency	Congleton
	tabling member printed	Fiona Bruce
	uin	119740
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>During the time period 1 January 2016 to 31 December 2016, it is estimated that approximately 90,500 tablets of ellaOne 30mg were dispensed against a prescription in pharmacies in the United Kingdom. In addition, it is estimated that there were a further 39,000 tablets of ellaOne 30mg purchased ‘over the counter’ in pharmacies (i.e. without a prescription) in the United Kingdom during the same time period.</p><p> </p><p>This usage data does not capture provision of ellaOne via family planning clinics or stock ordered directly from the manufacturer, via other hospitals or other wholesalers not captured by the database, and therefore some usage for ellaOne will not be included in these figures. For these reasons, the data should be interpreted with caution.</p><p> </p><p>The source of this data is MIDAS Quintiles.</p><p> </p><p>EllaOne is an ulipristal acetate-containing emergency hormonal contraceptive that is licensed for use within five days of unprotected sexual intercourse or contraceptive failure. It is classified as a female emergency contraceptive; it is not an abortifacient. It exerts its contraceptive action by preventing or delaying ovulation. EllaOne has never been studied as an abortifacient. It is not intended for use during pregnancy and should not be taken by any woman suspected or known to be pregnant.</p><p> </p><p>Following a High Court ruling in 2002, emergency contraception is a method of contraception not abortion. The decision confirms the Government’s long held position that a pregnancy begins at implantation and not fertilisation. This judgment means that this position is now established in law and is not a matter of policy.</p><p> </p><p>As with all other licensed medicines, the Medicines and Healthcare products Regulatory Agency (MHRA) keeps the safety of ellaOne under close review using a wide number of data sources. These include reports of suspected adverse drug reactions which include pregnancies; spontaneously provided by health professionals and patients through the ‘Yellow Card scheme’. Other sources of data that the MHRA reviews on a regular basis, and which may include information on safety and/or lack of efficacy or inappropriate use, include periodic safety update reports, renewals and variations to product licences. The MHRA also reviews important published medical literature and the results of any new clinical trials or epidemiological studies as they become available.</p><p> </p><p>As with all marketed medicines, the MHRA will continue to monitor the use of ellaOne. In the event that these monitoring processes identify information that suggest that ellaOne is used outside of its licensed indication, advice will be sought from the Commission on Human Medicines and its expert advisory groups. There are post-marketing regulatory measures in place to ensure that ellaOne is used as safely as possible. These measures include a European Union-wide pregnancy registry which collects data on pregnancy outcomes (including pregnancy maintenance and effects on the foetus or newborn) following exposure to ellaOne for any reason. The registry is available at the following link:</p><p><a href="http://www.hra-pregnancy-registry.com" target="_blank">www.hra-pregnancy-registry.com</a></p><p>Women and healthcare professionals involved in the care of pregnant women are asked to report ellaOne exposed pregnancies to the registry via the ellaOne prescribing information and patient leaflet, as well as via yearly letters sent by the marketing authorisation holder. Abortion clinics in particular are requested to ensure that every pregnant woman is asked whether she has taken emergency contraception and if so, to specify which product.</p><p> </p><p>The world-wide data available to date, including data from the EU pregnancy registry, do not suggest any safety concerns following exposure to ellaOne during pregnancy.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119736 119739 question first answered 21/12/2017 16:55:09 answering member 4067 label Biography information for Steve Brine
	tabling member	3958 label Biography information for Fiona Bruce

809057

	registered interest
	date	18/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Rickets: Carnforth
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department has received any reports of rickets in the Carnforth area in the last five years.
	tabling member constituency	Morecambe and Lunesdale
	tabling member printed	David Morris
	uin	120166
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>Information is not held in the format requested. The information available is shown in the table below. This shows a count of finished consultant episodes with a primary or secondary diagnosis of rickets, for the Lancashire Area Team of treatment, for the financial years between 2012/13 and 2016/17. The Lancashire Area Team of treatment includes the Carnforth area. Figures do not represent the number of different patients, as a person may have more than one episode of care in the same year.</p><p> </p><table><tbody><tr><td><p>Financial year</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td><td><p>2014-15</p></td><td><p>2015-16</p></td><td><p>2016-17</p></td></tr><tr><td><p>Lancashire Area Team of Treatment</p></td><td><p>10</p></td><td><p>7</p></td><td><p>5</p></td><td><p>7</p></td><td><p>5</p></td></tr></tbody></table><p> </p><p>Source: Hospital Episode Statistics, NHS Digital</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 11:54:32 answering member 4067 label Biography information for Steve Brine
	tabling member	4135 label Biography information for David Morris

806112

	registered interest
	date	13/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Bowel Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department has plans to reduce the screening age for bowel cancer to 50 years old.
	tabling member constituency	Bristol East
	tabling member printed	Kerry McCarthy
	uin	119313
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>Following the Ministerial approval of the United Kingdom National Screening Committee’s (UK NSC’s) recommendation to introduce Faecal Immunochemical Testing as the primary screen test in the NHS Bowel Cancer Screening Programme, the UK NSC commissioned the Sheffield School of Health and Related Research (ScHARR) to use existing evidence and modelling techniques to describe options for optimising bowel cancer screening. This includes at different cut off levels for the test and at various age ranges.</p><p> </p><p>The UK NSC will continue to work with ScHARR, and stakeholders, and will make a final recommendation in 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:24:21 answering member 4067 label Biography information for Steve Brine
	tabling member	1491 label Biography information for Kerry McCarthy

806035

	registered interest
	date	13/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department has made an assessment of the implementation of the Eligibility Criteria for Patient Transport Services guide.
	tabling member constituency	Edmonton
	tabling member printed	Kate Osamor
	uin	119244
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>No such assessments have been made. The provision of appropriate patient transport services is a matter for local National Health Service commissioners.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119245 question first answered 21/12/2017 16:37:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4515 label Biography information for Kate Osamor

806036

	registered interest
	date	13/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Patients: Transport
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department has made an assessment of the effect of outsourcing patient transport services on the quality of service provided.
	tabling member constituency	Edmonton
	tabling member printed	Kate Osamor
	uin	119245
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>No such assessments have been made. The provision of appropriate patient transport services is a matter for local National Health Service commissioners.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 119244 question first answered 21/12/2017 16:37:55 answering member 4067 label Biography information for Steve Brine
	tabling member	4515 label Biography information for Kate Osamor

805226

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Obesity: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department collects data to assess the performance of GPs in managing obesity in primary care.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118898
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>There is an indicator in the Quality and Outcomes Framework (QOF) related to general practices holding a register of obese patients. The contractor establishes and maintains a register of patients aged 18 years and over who have presented with a Body Mass Index of over 30 in the preceding 12 months. These indicators do not relate to performance of general practices in dealing with obesity.</p><p> </p><p>The QOF is a voluntary annual reward and incentive programme for all general practice surgeries in England, detailing practice achievement results. Prevalence data on 21 conditions is recorded and can be broken down sub-nationally to regional and general practice level. Information is voluntarily provided by 95.4% of general practices in England.</p><p> </p><p>QOF is part of the General Medical Services contracting arrangements. There may be similar schemes developed locally for Personal Medical Services (PMS) and Alternative Provider Medical Services (APMS) practices. However, as PMS and APMS are locally negotiated contracts, these are a matter for agreement between NHS England and the contractor concerned.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:04:44 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

805227

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Liver Diseases: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether his Department collects data to assess the access of patients with liver disease to multidisciplinary alcohol care teams.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	118899
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>There is no specific data available detailing the access of patients with liver disease to multidisciplinary alcohol care teams. In 2014 and 2016, Public Health England undertook national surveys of district general hospitals to further understand the number, capacity, and practices of alcohol care teams.</p><p>The results of the 2014 survey were published at:</p><p><a href="https://www.alcohollearningcentre.org.uk/News/-Alcohol-care-in-Englands-hospitals-An-opportunity-not-to-be-wasted-has-been-published-/" target="_blank">https://www.alcohollearningcentre.org.uk/News/-Alcohol-care-in-Englands-hospitals-An-opportunity-not-to-be-wasted-has-been-published-/</a></p><p>The results of the 2016 survey are due to be published in spring 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:12:10 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

830542

	registered interest
	date	25/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he plans to reduce the cost of liothyronine by procuring the drug from foreign suppliers; and if he will make a statement.
	tabling member constituency	Twickenham
	tabling member printed	Sir Vince Cable
	uin	125070
	answer	answer is ministerial correction date of answer 30/01/2018 answer text <p>The costs of branded medicines are controlled by the Pharmaceutical Price Regulation Scheme and the statutory scheme for branded medicines. Liothyronine is an unbranded generic medicine. For unbranded generic medicines, the Department encourages competition between suppliers to keep prices down. In primary care, community pharmacies are incentivised to source products at the lowest possible cost and in secondary care, competitive tenders ensure value-for-money to the National Health Service.</p><p> </p><p>Liothyronine is currently the subject of an investigation by the Competition and Markets Authority, which has provisionally found that the single supplier of the product abused its dominant position to overcharge the NHS by millions for liothyronine tablets. A provisional decision does not necessarily lead to an infringement decision. Where companies have breached competition law, the Department will seek damages and invest that money back into the NHS.</p><p> </p><p>Medicines legislation requires that only medicines licensed for use in the United Kingdom can be marketed in the UK.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 125067 question first answered 30/01/2018 17:14:17 answering member 4067 label Biography information for Steve Brine
	tabling member	207 label Biography information for Sir Vince Cable

804266

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he plans to provide incentives to medical students to enter general practice.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	118456
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>Health Education England (HEE) has implemented a range of improvements to increase the number of general practitioner (GP) training places to 3,250 each year. In 2017 3,157 new starters were recruited to training posts – this is the highest number of GP trainees ever.</p><p>NHS England, HEE, the British Medical Association and the Royal College of General Practitioners have been working together to increase the number of medical students choosing to enter specialty GP training.</p><p>NHS England is funding a £20,000 salary supplement (Targeted Enhanced Recruitment Scheme) to attract GP trainees to work in areas of the country where GP training places have been unfilled for a number of years. In 2018 up to 200 places will be offered.</p><p>The scheme is open to GP trainees committed to working for three years in areas identified by the GP National Recruitment Office as having the hardest to recruit to training places in England. GP training directors identified those areas which had the lowest fill rates consistently over the last four years.</p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:38:38 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

808884

	registered interest
	date	18/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Lung Diseases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he plans to establish a taskforce for lung health; and if he will make a statement.
	tabling member constituency	Leeds North West
	tabling member printed	Alex Sobel
	uin	119993
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>Improving care for people with lung disease is a key priority for the National Health Service. Whilst there are no new plans for a national respiratory strategy or programme, there is ongoing work around particular respiratory conditions. Recent progress includes publication of standards on a range of respiratory conditions and a national pilot to improve care of breathlessness. Recent campaign activity this year has focused on raising awareness of respiratory symptoms which could indicate heart or lung disease.</p><p> </p><p>NHS England and clinical commissioning groups have responsibility for determining the overall national approach to improve clinical outcomes from healthcare services for people with respiratory disease. The NHS Outcomes Framework sets out the Department's priority areas for the NHS. One of these is reducing early deaths from respiratory diseases.</p><p> </p><p>The Department is committed to working in partnership with its arm’s length bodies to ensure the progress of these joint initiatives.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 13:41:07 answering member 4067 label Biography information for Steve Brine
	tabling member	4658 label Biography information for Alex Sobel

805991

	registered interest
	date	13/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accountable Care Organisations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he has received representations from NHS Trusts to allow them to create accountable care organisations.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	119201
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Department has not received representations from National Health Service trusts. It is for local commissioners working with NHS England to decide who can use the draft contract. We believe it is right that local NHS leaders and clinicians have the autonomy to decide the best solutions to improve care for the patients they know best.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:39:44 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

816844

	registered interest
	date	05/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescription Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether he has received any representations on difficulties experienced by GPs in obtaining (a) diamorphine and (b) other prescription drugs; and whether he is taking steps to increase the ease of access to such drugs by GPs.
	tabling member constituency	Weaver Vale
	tabling member printed	Mike Amesbury
	uin	121271
	answer	answer is ministerial correction date of answer 10/01/2018 answer text <p>The Department has not received any queries on behalf of general practitioners about diamorphine supplies. However, we are aware that supply issues do occasionally occur with prescription drugs. The Department works closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, clinical experts, and others operating in the supply chain to help prevent shortages and to ensure that the impact on patients is minimised when they do arise.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 10/01/2018 11:14:34 answering member 4067 label Biography information for Steve Brine
	tabling member	4667 label Biography information for Mike Amesbury

810727

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Accountable Care Organisations
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether Accountable Care Organisations are permitted to make a profit.
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	121072
	answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>No Accountable Care Organisation yet exists in the National Health Service in England, as no contract to commission a provider organisation to operate in this way has yet been awarded. In the very small number of pilot areas in which this process is well advanced, indications are that the lead provider will be a NHS foundation trust. The powers of an NHS foundation trust to borrow are prescribed by section 46 of the NHS Act 2006 and related statutory provisions.</p><p> </p><p>NHS foundation trusts are not-for-profit, public benefit corporations. They are part of the NHS and can retain any surpluses they make in order to invest in services for patients and service users. They can also, subject to the conditions set by their regulator, NHS Improvement, borrow money for the same purpose. All of their activities are subject to meeting the requirements of the regulator.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 121071 question first answered 11/01/2018 16:47:04 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

804253

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when will Orkambi be made available for the treatment of cystic fibrosis on the NHS.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	118431
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>In July 2016, the National Institute for Health and Care Excellence (NICE), the independent body that develops guidance on drugs and treatments for clinical and cost effectiveness for the National Health Service in England, was unable to recommend Orkambi as a cost effective use of NHS resources. NICE concluded that, although clinically significant for managing cystic fibrosis, the longer term outcomes and benefits were not sufficient to justify its considerable costs. Orkambi is not therefore routinely available to NHS patients with cystic fibrosis.</p><p> </p><p>Since then there has been a constructive dialogue underway between the company, NHS England and NICE, including discussion hosted through NICE’s confidential ‘Office for Market Access’, although NICE is yet to receive any fresh proposals from Vertex, the company that manufactures Orkambi. Both NHS England and NICE have been consistent in advice to Vertex, that progress can only be made by working through NICE’s appraisal processes and the existing commercial framework.</p><p> </p><p>Any funding decisions in the absence of positive NICE technology appraisal guidance should be made by NHS commissioners based on an assessment of the available evidence and on the basis of an individual patient’s clinical circumstances.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:36:40 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

804392

	registered interest
	date	11/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Diabetes: Leicestershire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when the £600,000 of funding from the Diabetes Transformation Fund was transferred to Leicester, Leicestershire and Rutland sustainability and transformation partnership.
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	uin	118542
	answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>NHS England confirms that Diabetes Transformation funding of £815,000 has been awarded to the Leicester, Leicestershire and Rutland Sustainability Transformation Partnership area, as announced on 20 April. The 1st quarter’s payment was made on 30 June, the 2nd quarter’s payment was made on 29 September and the 3rd quarter’s payment will be made on 29 December.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:41:22 answering member 4067 label Biography information for Steve Brine
	tabling member	338 label Biography information for Keith Vaz

806251

	registered interest
	date	13/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when the last impact assessment was undertaken of the prescription charge medical exemption list; if he will publish that impact assessment; and whether that impact assessment makes reference to the disproportionate effect on certain groups of Sickle Cell or Lupus.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	119443
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Department has not undertaken a formal impact assessment on the potential cost of eliminating or reducing prescription charges for people with long-term medical conditions not already covered by a medical exemption. However, the Prescription Charges Review (the Review) undertaken by Professor Sir Ian Gilmore on behalf of the Department, and published in 2010, estimated that extending exemption, at that time, to all those with a long-term condition would lead to a loss in revenue of between £360 and £430 million. This document is publicly available at:</p><p><a href="https://www.gov.uk/government/publications/prescription-charges-review-the-gilmore-report" target="_blank">https://www.gov.uk/government/publications/prescription-charges-review-the-gilmore-report</a></p><p>The Review does not make specific reference to sufferers of lupus, however, the All Party Parliamentary Group on Sickle Cell and Thalassaemia and the Sickle Cell Society provided written evidence to the Review.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:35:51 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

809044

	registered interest
	date	18/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Sleep Apnoea
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he plans to publish the Review of the Clinical Pathway for Sleep Apnoea.
	tabling member constituency	Sheffield, Heeley
	tabling member printed	Louise Haigh
	uin	120153
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>The Review of the Clinical Pathway for Sleep Apnoea is included on the National Institute for Health and Care Excellence’s priority lists and scoping will begin in the new year.</p><p> </p><p>There are no plans of establishing a national programme to provide fast-track treatment of obstructive sleep apnoea for vocational drivers.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120152 120154 question first answered 22/12/2017 11:51:19 answering member 4067 label Biography information for Steve Brine
	tabling member	4473 label Biography information for Louise Haigh

806108

	registered interest
	date	13/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when he plans to publish the Cost Effectiveness Methodology for Immunisation Programmes and Procurement report into vaccine cost-effectiveness.
	tabling member constituency	Faversham and Mid Kent
	tabling member printed	Helen Whately
	uin	119309
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The Cost Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) report is technically complex with potential implications that could extend beyond immunisation. This report was referred to the Appraisal Alignment Working Group (AAWG) for further advice. The Department will consider the CEMIPP report alongside the AAWG advice and remains committed to publishing the CEMIPP report in due course.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:44:23 answering member 4067 label Biography information for Steve Brine
	tabling member	4527 label Biography information for Helen Whately

810590

	registered interest
	date	21/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Public Health England
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the timetable is for the implementation of the recommendations of the McNeil Review into cancer patient data at Public Health England (PHE), and what effect that implementation will have of PHE's adherence to NHS rules on consent.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	120935
	answer	answer is ministerial correction date of answer 08/01/2018 answer text <p>The McNeil Review into Public Health England’s (PHE) data collection and data management functions considered whether, how and when these should be transferred to NHS Digital. It identified four tranches of data, based on the complexity of the processes involved in the collection and quality assurance of the data and recommended that cancer registration be considered within tranche three and only after the earlier tranches had been completed; this is expected to take at least three years. PHE and NHS Digital are currently scoping the work programme to implement the review’s recommendations. PHE will continue to process cancer data in line with current legal gateways and the National Health Service rules on consent, taking into account any changes that may arise with emerging legislative and policy frameworks.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/01/2018 16:44:38 answering member 4067 label Biography information for Steve Brine
	tabling member	1538 label Biography information for Rosie Cooper

808978

	registered interest
	date	18/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ovarian Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the timetable is for a decision on the next round of cancer audits; and whether ovarian cancer will be included within those audits.
	tabling member constituency	North East Derbyshire
	tabling member printed	Lee Rowley
	uin	120087
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England, the Welsh Government and the Healthcare Quality Improvement Partnership are currently recommissioning the cancer audits that sit within the National Clinical Audit and Patient Outcomes Programme portfolio and have been charged with achieving greater alignment to produce a more sustainable delivery model. Discussions will take place over the next year on potential new topics, such as ovarian cancer and any new audits will draw on data that is already available and routinely collected, wherever possible.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 12:03:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4652 label Biography information for Lee Rowley

809547

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the level of availability of cancer gene tests is on the NHS; and whether the NHS prioritises such tests for people whose families have a history of cancer.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	120205
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England is committed to implementing the Independent Cancer Taskforce’s recommendations on molecular diagnostics, meaning that around 25,000 additional people will have their cancers genetically tested every year to identify the most effective treatments. NHS England will continue to invest in building the infrastructure for genomics and by the end of 2018/19, will have developed a genomic medicine service for England, underpinned by a new consolidated genomic laboratory infrastructure and facilitated by informatics, data and analytical platforms to enable the sequencing data we generate to improve clinical practice. Once established, the new genomic laboratory infrastructure for the National Health Service in England will support rare, inherited and acquired disease, to support the NHS to deliver personalised medicine to all eligible patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 11:43:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

806522

	registered interest
	date	14/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the cost to the public purse was of cancer services in each year since 2001-02.
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	uin	119598
	answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>The information requested is not routinely collected. In its 2015 report, Progress in improving cancer services and outcomes in England, the National Audit Office estimated that the cost to the National Health Service of cancer services in 2012-13 was £6.7 billion.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 16:20:36 answering member 4067 label Biography information for Steve Brine
	tabling member	4244 label Biography information for Jonathan Ashworth

818692

	registered interest
	date	08/01/2018
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Phenytoin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average cost to the public purse has been of (a) an individual prescription and (b) treating a patient with the drug Phenytoin in each of the last five years; and if he will make a statement.
	tabling member constituency	Kingston upon Hull West and Hessle
	tabling member printed	Emma Hardy
	uin	121456
	answer	answer is ministerial correction date of answer 11/01/2018 answer text <p>The average Net Ingredient Cost (NIC) per prescription item for Phenytoin written in the United Kingdom and dispensed in England is set out below. Information is split by Phenytoin and Phenytoin Sodium with a figure provided for the total.</p><p> </p><p>Prescription items and NIC per prescription item (£)</p><table><tbody><tr><td><p> </p></td><td colspan="2"><p>Phenytoin</p></td><td colspan="2"><p>Phenytoin Sodium</p></td><td colspan="2"><p>Total</p></td></tr><tr><td><p> </p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td><td><p>Items</p></td><td><p>NIC per Item (£)</p></td></tr><tr><td><p>2012</p></td><td><p>39,117</p></td><td><p>15.76</p></td><td><p>970,031</p></td><td><p>21.52</p></td><td><p>1,009,148</p></td><td><p>21.30</p></td></tr><tr><td><p>2013</p></td><td><p>38,667</p></td><td><p>12.78</p></td><td><p>934,428</p></td><td><p>54.48</p></td><td><p>973,095</p></td><td><p>52.82</p></td></tr><tr><td><p>2014</p></td><td><p>36,017</p></td><td><p>12.90</p></td><td><p>894,176</p></td><td><p>48.76</p></td><td><p>930,193</p></td><td><p>47.38</p></td></tr><tr><td><p>2015</p></td><td><p>33,473</p></td><td><p>12.14</p></td><td><p>847,781</p></td><td><p>46.49</p></td><td><p>881,254</p></td><td><p>45.19</p></td></tr><tr><td><p>2016</p></td><td><p>31,360</p></td><td><p>12.16</p></td><td><p>800,820</p></td><td><p>45.19</p></td><td><p>832,180</p></td><td><p>43.94</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis</p><p> </p><p>Information is not held centrally on the costs of treating a patient with phenytoin.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/01/2018 16:55:52 answering member 4067 label Biography information for Steve Brine
	tabling member	4645 label Biography information for Emma Hardy

810314

	registered interest
	date	20/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	King's College Hospital
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average cancer treatment waiting time was at King's College Hospital Denmark Hill site in each of the last seven years.
	tabling member constituency	Camberwell and Peckham
	tabling member printed	Ms Harriet Harman
	uin	120780
	answer	answer is ministerial correction date of answer 08/01/2018 answer text <p>Data is not available in the format requested.</p><p> </p><p>NHS England publishes quarterly performance data on cancer waiting times standards, along with monthly provisional statistics. This is published at trust level rather than by individual hospital site and can be accessed at:</p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/01/2018 16:47:27 answering member 4067 label Biography information for Steve Brine
	tabling member	150 label Biography information for Ms Harriet Harman

805289

	registered interest
	date	12/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	GP at Hand
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the average age is of patients registered with the GP at hand service?
	tabling member constituency	Ellesmere Port and Neston
	tabling member printed	Justin Madders
	uin	118961
	answer	answer is ministerial correction date of answer 20/12/2017 answer text <p>We are unable to provide this information as it is not held centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/12/2017 17:03:39 answering member 4067 label Biography information for Steve Brine
	tabling member	4418 label Biography information for Justin Madders

809083

	registered interest
	date	18/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mechanical Thrombectomy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what support his Department provides to NHS England to ensure that NHS Trusts can provide mechanical thrombectomies for the treatment of stroke.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	120192
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England is working to develop well-staffed and effective units capable of delivering high quality thrombectomy. NHS England is supporting networking between thrombectomy centres to cover extended daytime hours while service development is under discussion in each of the regions. Full 24/7 implementation of this relatively new technique across the country will take time. NHS England will explore the possibility of providing care to patients in remote areas using helicopter transfer.</p><p> </p><p>NHS England is initially proposing to set up 24 thrombectomy centres providing care 24 hours a day, seven days a week which would require a minimum of five interventional clinicians for each centre (120 clinicians). Ultimately NHS England expects to need at least 30 centres to provide equitable geographical coverage, which would require 150 interventionists.</p><p> </p><p>To strengthen the available workforce, models of training are being discussed by Health Education England (HEE) and the General Medical Council (GMC). HEE is developing models of training for interventional radiologists and a credential model in collaboration with the GMC.</p><p> </p><p>NHS services in Scotland and Wales are matters for the Scottish and Welsh Governments.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120190 120191 120193 120204 question first answered 22/12/2017 11:48:17 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah

809601

	registered interest
	date	19/12/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Mechanical Thrombectomy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what support his Department plans to offer to those NHS trusts in those areas unlikely to be able to offer mechanial thrombectomy as a treatment immediately.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	120249
	answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England does not anticipate being able to offer thrombectomy to all eligible stroke patients immediately, because of the need to develop and train further specialists to undertake the procedure. NHS England is initially proposing to set up 24 thrombectomy centres providing care 24 hours a day, seven days a week which would require a minimum of five interventional clinicians for each centre (120 clinicians). Ultimately NHS England expects to need at least 30 centres to provide equitable geographical coverage, which would require 150 interventionists.</p><p>NHS England anticipates that it will take a minimum of five years to achieve full 24/7 services and in the initial roll out phase of implementation most services will not be in a position to safely deliver this service 24/7, as delivering thrombectomy is a complex and highly technical procedure.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120250 question first answered 22/12/2017 11:41:14 answering member 4067 label Biography information for Steve Brine
	tabling member	4124 label Biography information for Chi Onwurah